The last 5 years have seen the emergence of efficacious peptide-based therapies for obesity treatment that target glucagon-like peptide-1 receptor (GLP-1R), either selectively or via co-activation with related receptors, such as the glucose-dependent insulinotropic polypeptide and/or glucagon receptors 1
William Clearfield, a graduate of LaSalle College and the College of Osteopathic Medicine and Surgery, Des Moines, IA., completed a rotating internship and served as an OB/GYN resident at Metropolitan Hospital, Philadelphia, PA
There were no changes in training or dietary protocols other than the administration of glutathione intravenously
In addition, some compounded GLP-1s come in different concentrations than the standard forms
This visceral fat settles around the organs and is associated with greater risks of inflammation, insulin resistance, and cardiovascular disease
Because Wegovy is a brand-name medication, it is typically the highest-cost GLP-1 option